Andrea Eisen

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.

Ellen Warner, Linda Rabeneck, W. Meschino, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Ellen Warner, Ping Sun, Olufunmilayo I Olopade, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validity of Models for Predicting BRCA1 and BRCA2 Mutations

Leif E. Peterson, Giovanni Parmigiani, Li Hsu, 2007, Annals of Internal Medicine.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Leif E. Peterson, Giovanni Parmigiani, Christopher I Amos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.

Eric Sauerbrei, Stephen Chia, Karen A Gelmon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The risk of breast cancer in women with a BRCA1 mutation from North America and Poland

Susan L Neuhausen, Jan Lubinski, Kevin Sweet, 2012, International journal of cancer.

Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers

Jan Lubinski, Charis Eng, Ping Sun, 2006, International journal of cancer.

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer

Miriam Zacksenhouse, Sharon Nofech-Mozes, M. Zacksenhouse, 2017, PloS one.